Trial Profile
A trial of aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 04 Feb 2016 New trial record